Donna Skee

1.2k total citations
26 papers, 959 citations indexed

About

Donna Skee is a scholar working on Genetics, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Donna Skee has authored 26 papers receiving a total of 959 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 8 papers in Public Health, Environmental and Occupational Health and 6 papers in Molecular Biology. Recurrent topics in Donna Skee's work include Chronic Lymphocytic Leukemia Research (8 papers), Reproductive Health and Contraception (8 papers) and Lymphoma Diagnosis and Treatment (6 papers). Donna Skee is often cited by papers focused on Chronic Lymphocytic Leukemia Research (8 papers), Reproductive Health and Contraception (8 papers) and Lymphoma Diagnosis and Treatment (6 papers). Donna Skee collaborates with scholars based in United States, Belgium and France. Donna Skee's co-authors include Frankie A. Wong, Jaya Natarajan, Damayanthi Devineni, Larry S. Abrams, Joseph Murphy, Juthamas Sukbuntherng, Jan de Jong, An Vandebosch, Marcus Hompesch and Sherwyn Schwartz and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Donna Skee

25 papers receiving 929 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Donna Skee United States	16	257	257	255	173	169	26	959
G. De Sandre Italy	19	257 1.0×	78 0.3×	215 0.8×	163 0.9×	55 0.3×	74	1.4k
Eric Villard France	19	437 1.7×	78 0.3×	338 1.3×	67 0.4×	84 0.5×	46	2.0k
Chantal Le Guellec France	21	213 0.8×	145 0.6×	26 0.1×	78 0.5×	120 0.7×	59	1.3k
Samir Mallat Lebanon	18	131 0.5×	57 0.2×	67 0.3×	69 0.4×	60 0.4×	41	911
A. van den Ende Netherlands	16	165 0.6×	58 0.2×	245 1.0×	301 1.7×	137 0.8×	42	1.4k
Kostas Stylianou Greece	19	215 0.8×	55 0.2×	166 0.7×	73 0.4×	31 0.2×	77	1.0k
Julio Dávila Spain	12	185 0.7×	79 0.3×	44 0.2×	65 0.4×	47 0.3×	33	759
Trefor Higgins Canada	19	161 0.6×	398 1.5×	385 1.5×	320 1.8×	103 0.6×	70	1.2k
U. Essers Germany	9	148 0.6×	139 0.5×	62 0.2×	350 2.0×	76 0.4×	38	1.1k
Polly E. Kintzel United States	14	101 0.4×	45 0.2×	38 0.1×	67 0.4×	112 0.7×	28	890

Countries citing papers authored by Donna Skee

Since Specialization

Citations

This map shows the geographic impact of Donna Skee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna Skee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna Skee more than expected).

Fields of papers citing papers by Donna Skee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna Skee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna Skee. The network helps show where Donna Skee may publish in the future.

Co-authorship network of co-authors of Donna Skee

This figure shows the co-authorship network connecting the top 25 collaborators of Donna Skee. A scholar is included among the top collaborators of Donna Skee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donna Skee. Donna Skee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kang, Lijuan, Weimin Wang, Donna Skee, et al.. (2016). UPLC–MS/MS assay for the simultaneous determination of ethinyl estradiol, norgestimate and 17-Desacetyl norgestimate at low pg/mL in human plasma. Journal of Chromatography B. 1017-1018. 1–9. 12 indexed citations

Jong, Jan de, Donna Skee, Peter Hellemans, et al.. (2016). Single-dose pharmacokinetics of ibrutinib in subjects with varying degrees of hepatic impairment^*. Leukemia & lymphoma. 58(1). 185–194. 17 indexed citations

Tabernero, Josep, Jeffrey R. Infante, Alain C. Mita, et al.. (2016). Pharmacokinetics (PK) of the pan-FGFR inhibitor erdafitinib in urothelial carcinoma. Annals of Oncology. 27. vi273–vi273. 6 indexed citations

Jong, Jan de, Juthamas Sukbuntherng, Donna Skee, et al.. (2015). The effect of food on the pharmacokinetics of oral ibrutinib in healthy participants and patients with chronic lymphocytic leukemia. Cancer Chemotherapy and Pharmacology. 75(5). 907–916. 60 indexed citations

Jong, Jan de, Donna Skee, Joe Murphy, et al.. (2015). Effect of CYP3A perpetrators on ibrutinib exposure in healthy participants. Pharmacology Research & Perspectives. 3(4). e00156–e00156. 81 indexed citations

Vries, Ronald de, Johan W. Smit, Peter Hellemans, et al.. (2015). Stable isotope‐labelled intravenous microdose for absolute bioavailability and effect of grapefruit juice on ibrutinib in healthy adults. British Journal of Clinical Pharmacology. 81(2). 235–245. 58 indexed citations

Scheers, Ellen, Laurent Leclercq, Jan de Jong, et al.. (2014). Absorption, Metabolism, and Excretion of Oral 14C Radiolabeled Ibrutinib: An Open-Label, Phase I, Single-Dose Study in Healthy Men. Drug Metabolism and Disposition. 43(2). 289–297. 105 indexed citations

Devineni, Damayanthi, Prasarn Manitpisitkul, Joseph Murphy, et al.. (2014). Effect of canagliflozin on the pharmacokinetics of glyburide, metformin, and simvastatin in healthy participants. Clinical Pharmacology in Drug Development. 4(3). 226–236. 18 indexed citations

Jong, Jan de, Juthamas Sukbuntherng, Donna Skee, et al.. (2014). Abstract 4637: Evaluation of the pharmacokinetics and food effect of oral ibrutinib in healthy subjects and chronic lymphocytic leukemia patients. Cancer Research. 74(19_Supplement). 4637–4637. 2 indexed citations

10.

Devineni, Damayanthi, Linda Morrow, Marcus Hompesch, et al.. (2012). Canagliflozin improves glycaemic control over 28 days in subjects with type 2 diabetes not optimally controlled on insulin. Diabetes Obesity and Metabolism. 14(6). 539–545. 192 indexed citations

11.

Moreau, Philippe, Vadim Doronin, Alexander Schmidt, et al.. (2012). Pharmacokinetic, Pharmacodynamic and Covariate Analysis of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients with Relapsed Multiple Myeloma. Clinical Pharmacokinetics. 51(12). 823–829. 68 indexed citations

12.

Hellmann, Andrzej, Simon Rule, Jan Walewski, et al.. (2011). Effect of Cytochrome P450 3A4 Inducers on the Pharmacokinetic, Pharmacodynamic and Safety Profiles of Bortezomib in Patients with Multiple Myeloma or Non-Hodgkinʼs Lymphoma. Clinical Pharmacokinetics. 50(12). 781–791. 30 indexed citations

13.

Barbour, April, Stephan Schmidt, Sreedharan Sabarinath, et al.. (2009). Soft-Tissue Penetration of Ceftobiprole in Healthy Volunteers Determined by In Vivo Microdialysis. Antimicrobial Agents and Chemotherapy. 53(7). 2773–2776. 32 indexed citations

14.

Skee, Donna. (2008). Soft Tissue Penetration of Ceftobiprole Following Single Dose Administration in Healthy Adults. 46th Annual Meeting. 1 indexed citations

15.

Devineni, Damayanthi, Donna Skee, Nicole Vaccaro, et al.. (2007). Pharmacokinetics and Pharmacodynamics of a Transdermal Contraceptive Patch and an Oral Contraceptive. The Journal of Clinical Pharmacology. 47(4). 497–509. 48 indexed citations

16.

Skee, Donna, et al.. (2007). Pharmacokinetic model and simulations of dose conversion from immediate- to extended-release tramadol. Current Medical Research and Opinion. 23(2). 275–284. 16 indexed citations

17.

Murthy, Bindu, Donna Skee, David Wexler, et al.. (2007). P779 Pharmacokinetics of ceftobiprole following single and multiple intravenous infusions administered to healthy subjects. International Journal of Antimicrobial Agents. 29. S194–S195. 5 indexed citations

18.

Abrams, Larry S., Donna Skee, Jaya Natarajan, & Frankie A. Wong. (2002). Pharmacokinetic overview of Ortho Evra™/Evra™. Fertility and Sterility. 77(2 Suppl 2). 3–12. 73 indexed citations

19.

Abrams, Larry S., Donna Skee, Jaya Natarajan, Frankie A. Wong, & Gary D. Anderson. (2002). Pharmacokinetics of a contraceptive patch (Evra^™/Ortho Evra^™) containing norelgestromin and ethinyloestradiol at four application sites. British Journal of Clinical Pharmacology. 53(2). 141–146. 71 indexed citations

20.

Skee, Donna, et al.. (2001). Multiple-dose pharmacokinetics of a contraceptive patch in healthy women participants. Contraception. 64(5). 287–294. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact